The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology
- PMID: 18404368
- DOI: 10.1007/s10549-008-0007-4
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology
Abstract
Although invasive ductal (IDC) and lobular (ILC) breast carcinomas are well characterised in the literature, the biological and clinical significance of mixed tumours with both ductal and lobular components has not been investigated. In the current study, we have examined a well-characterised series of breast carcinoma with a long term follow-up that comprised 140 mixed tumours, 2170 IDC and 380 pure ILC.
Results: Mixed tumours constituted 3.6% of all cases. The majority (59%) of the mixed tumours were grade 2 compared to 33% in IDC and 88% in ILC. Positive lymph nodes (LN) were found in 41% and definite vascular invasion (VI) in 26% of the cases. DCIS was detected in 123 (89%) and LCIS in 43 (31%) (both DCIS and LCIS were found in 39 cases). The majority of tumours were predominantly (>50 of tumour area) of ductal type (57%). When compared to pure IDC, mixed tumours showed an association with lower grade, ER positivity and lower frequency of development of distant metastases. When compared to pure ILC, mixed tumours showed an association with higher grade, positive LN metastasis, VI and development of regional metastasis. After adjustment for grade most of these differences were no longer apparent. There was an association between histologic type of carcinoma in LN metastasis and the predominant histologic type of the primary tumour. Mixed tumours showed metastatic patterns similar to that of ILC with frequent metastasis to bone. No clinically meaningful differences in survival were found between these mixed carcinomas and pure IDC or ILC of the breast or between mixed tumours with predominantly ductal or lobular phenotype.
Similar articles
-
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.Eur J Cancer. 2008 Jan;44(1):73-83. doi: 10.1016/j.ejca.2007.10.009. Epub 2007 Nov 26. Eur J Cancer. 2008. PMID: 18035533
-
Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.Breast Cancer. 2017 Sep;24(5):667-672. doi: 10.1007/s12282-017-0753-4. Epub 2017 Jan 20. Breast Cancer. 2017. PMID: 28108967
-
[Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):437-41. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25327790 Chinese.
-
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.Breast Cancer Res Treat. 2022 Jun;193(2):253-264. doi: 10.1007/s10549-022-06572-w. Epub 2022 Mar 26. Breast Cancer Res Treat. 2022. PMID: 35347549 Review.
-
Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis.Clin Breast Cancer. 2020 Aug;20(4):e516-e528. doi: 10.1016/j.clbc.2020.03.007. Epub 2020 Mar 28. Clin Breast Cancer. 2020. PMID: 32362500
Cited by
-
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast.Mod Pathol. 2025 Jul 3;38(9):100837. doi: 10.1016/j.modpat.2025.100837. Online ahead of print. Mod Pathol. 2025. PMID: 40617531 Review.
-
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.Breast Cancer Res. 2015 Jan 30;17(1):12. doi: 10.1186/s13058-015-0519-x. Breast Cancer Res. 2015. PMID: 25849106 Free PMC article. Review.
-
Update on lobular lesions of the breast.Histopathology. 2023 Jan;82(1):36-52. doi: 10.1111/his.14829. Histopathology. 2023. PMID: 36482279 Free PMC article. Review.
-
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol. 2018 Apr;244(4):460-468. doi: 10.1002/path.5040. Epub 2018 Mar 9. J Pathol. 2018. PMID: 29344954 Free PMC article.
-
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.Breast Cancer Res Treat. 2023 Jul;200(2):217-224. doi: 10.1007/s10549-023-06959-3. Epub 2023 May 21. Breast Cancer Res Treat. 2023. PMID: 37210429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical